Claude Maraoui
Vermögen: 17 Mio $ am 30.06.2026
Vermögen: 17 Mio $ am 30.06.2026
Mr. Claude Maraoui is a President, Chief Executive Officer & Director at Journey Medical Corp.
and a Member at American Academy of Dermatology.
He is on the Board of Directors at Journey Medical Corp.
Mr. Maraoui was previously employed as a Vice President-Dermatology Sales by Medicis Pharmaceutical Corp.
He received his undergraduate degree from Rutgers State University of New Jersey.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
JOURNEY MEDICAL CORP. 11.31% | 22.04.2026 | 2’435’990 ( 11.31% ) | 17 Mio $ | 30.06.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| JOURNEY MEDICAL CORPORATION | Gründer | 01.10.2014 |
American Academy of Dermatology
American Academy of Dermatology Miscellaneous Commercial ServicesCommercial Services Operates as dermatologists organizations | Corporate Officer/Principal | - |
| Unternehmen | Position | Ende |
|---|---|---|
| MEDICIS PHARMACEUTICAL CORP | Corporate Officer/Principal | 01.04.2013 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 4 |
|---|---|
Medicis Pharmaceutical Corp.
Medicis Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical products for dermatological usages | Health Technology |
Rutgers State University of New Jersey
Rutgers State University of New Jersey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
American Academy of Dermatology
American Academy of Dermatology Miscellaneous Commercial ServicesCommercial Services Operates as dermatologists organizations | Commercial Services |
Journey Medical Corp.
Journey Medical Corp. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products for the treatment of dermatological treatment conditions | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen